Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a new release or update to the page’s documentation. This change does not modify the study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-15T14:35:51.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, indicating a tooling or platform update rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:14.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:01.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision badge updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:57:49.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:40:09.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2; previous notices including v3.4.1 and funding/operational status messages have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:22:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.